Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

6.89USD
14 Dec 2018
Change (% chg)

$0.06 (+0.88%)
Prev Close
$6.83
Open
$6.61
Day's High
$6.96
Day's Low
$6.61
Volume
16,477
Avg. Vol
36,199
52-wk High
$23.68
52-wk Low
$5.51

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.42 December 15 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2 5.45 9.50 1.40 --
Quarter Ending Mar-19 1 25.00 25.00 25.00 --
Year Ending Dec-18 2 33.99 38.07 29.90 36.78
Year Ending Dec-19 2 18.75 25.00 12.50 15.70
Earnings (per share)
Quarter Ending Dec-18 2 -0.42 -0.17 -0.67 -0.68
Quarter Ending Mar-19 1 0.18 0.18 0.18 --
Year Ending Dec-18 2 -1.58 -1.32 -1.84 -1.48
Year Ending Dec-19 2 -2.00 -1.40 -2.60 -2.81

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 6.43 6.12 0.32 4.92
Quarter Ending Jun-18 8.80 11.67 2.87 32.66
Quarter Ending Mar-18 9.90 10.78 0.88 8.90
Quarter Ending Dec-17 8.88 11.28 2.41 27.12
Quarter Ending Sep-17 3.07 8.78 5.71 186.33
Earnings (per share)
Quarter Ending Sep-18 -0.37 -0.38 0.01 -1.79
Quarter Ending Jun-18 -0.35 -0.41 0.06 -16.05
Quarter Ending Mar-18 -0.29 -0.36 0.07 -24.14
Quarter Ending Dec-17 -0.35 -0.15 0.20 -57.63
Quarter Ending Sep-17 -0.74 -0.29 0.45 -60.98

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5.45 5.45 15.77 15.21 --
Quarter Ending Mar-19 25.00 25.00 -- -- --
Year Ending Dec-18 33.99 33.99 43.85 42.27 36.78
Year Ending Dec-19 18.75 18.75 28.15 28.15 15.70
Earnings (per share)
Quarter Ending Dec-18 -0.42 -0.42 -0.04 -0.07 -0.68
Quarter Ending Mar-19 0.18 0.18 -- -- --
Year Ending Dec-18 -1.58 -1.58 -1.18 -1.11 -1.48
Year Ending Dec-19 -2.00 -2.00 -1.82 -1.82 -2.81

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 1
Quarter Ending Mar-19 0 0 -- --
Year Ending Dec-18 0 0 0 2
Year Ending Dec-19 0 0 0 1
Earnings
Quarter Ending Dec-18 0 0 0 2
Quarter Ending Mar-19 0 0 -- --
Year Ending Dec-18 0 0 0 2
Year Ending Dec-19 0 0 0 2